New derivatives of verapamil (1) modified with nitroxides and their precursors were synthesized and screened for reactive oxygen species (ROS)-scavenging activities. The basic structure was modified by changing the nitrile group to an amide or the methyl substituent on tertiary nitrogen with nitroxides and their reduced forms (hydroxylamine and secondary amines). Among the new verapamil derivatives compound 16B [Mohan, I. K.; Kahn, M.; Wisel, S.; Selvendiran, K.; Sridhar, A.; Carnes, C.A.; Bognár, B.; Kálai, T.; Hideg, K.; Kuppusamy, P. Am. J. Physiol. Heart Circ. Physiol.2009, 296, 140], modified with hydroxylamine salt of 2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridine-1-yloxyl proved to be the best ROS scavenger in vitro and protected HSMC and CHO cells against H(2)O(2) induced damage. Copyright 2010 Elsevier Ltd. All rights reserved.
New derivatives of n class="Chemical">verapamil (1) modified with nitroxides and their precursors were synthesized and screened for reactive oxygen species (ROS)-scavenging activities. The basic structure was modified by changing the nitrile group to an amide or the methyl substituent on tertiary nitrogen with nitroxides and their reduced forms (hydroxylamine and secondary amines). Among the new verapamil derivatives compound 16B [Mohan, I. K.; Kahn, M.; Wisel, S.; Selvendiran, K.; Sridhar, A.; Carnes, C.A.; Bognár, B.; Kálai, T.; Hideg, K.; Kuppusamy, P. Am. J. Physiol. Heart Circ. Physiol.2009, 296, 140], modified with hydroxylamine salt of 2,2,6,6-tetramethyl-1,2,3,6-tetrahydropyridine-1-yloxyl proved to be the best ROS scavenger in vitro and protected HSMC and CHO cells against H(2)O(2) induced damage. Copyright 2010 Elsevier Ltd. All rights reserved.
Authors: P Twomey; J Taira; W DeGraff; J B Mitchell; A Russo; M C Krishna; O H Hankovszky; L Frank; K Hideg Journal: Free Radic Biol Med Date: 1997 Impact factor: 7.376
Authors: M C Krishna; W DeGraff; O H Hankovszky; C P Sár; T Kálai; J Jeko; A Russo; J B Mitchell; K Hideg Journal: J Med Chem Date: 1998-08-27 Impact factor: 7.446
Authors: Z Marton; R Halmosi; B Horvath; T Alexy; G Kesmarky; J Vekasi; I Battyany; K Hideg; K Toth Journal: J Cardiovasc Pharmacol Date: 2001-11 Impact factor: 3.105
Authors: K Mitani; T Yoshida; S Sakurai; K Morikawa; Y Iwanaga; E Koshinaka; H Kato; Y Ito Journal: Chem Pharm Bull (Tokyo) Date: 1988-01 Impact factor: 1.645
Authors: B Villari; G Ambrosio; P Golino; M Ragni; A Focaccio; I Tritto; M Salvatore; M Chiariello Journal: Am Heart J Date: 1993-01 Impact factor: 4.749
Authors: Tamás Kálai; Jitka Petrlova; Mária Balog; Hnin Hnin Aung; John C Voss; Kálmán Hideg Journal: Eur J Med Chem Date: 2011-02-03 Impact factor: 6.514